In fact, although GATA-1 mutations are a common hallmark of ML-DS cases and are critical for leukaemia progression, the development of ML-DS requires a third hit represented by the acquisition of additional molecular defects, predominantly in cohesin complex genes such as STAG2 [22,27]. Here, STAG2 is linked to Dravet syndrome.